AHPA statement on confirmation of Dr. Gottlieb as FDA commissioner

Technical Workshops

AHPA regularly presents in-person technical workshops to train the herbal products industry on the latest tools and methods that help ensure high-quality products and compliance with federal and state regulations.

Upcoming Events

AHPA statement on confirmation of Dr. Gottlieb as FDA commissioner

Dr. Gottlieb's views on dietary supplements are consistent with industry views

Author: Haley (Admin)/Wednesday, May 10, 2017/Categories: AHPA News Release, Legal Alert, News Release, Update, Press Room, Front Page, Government Relations Committee, Advocacy

American Herbal Products Association (AHPA) President Michael McGuffin issued the following statement regarding the Senate confirmation of Dr. Scott Gottlieb as FDA commissioner.

"AHPA congratulates Dr. Gottlieb on his confirmation and looks forward to supporting FDA efforts to enforce dietary supplement laws and regulations as intended by Congress. Dr. Gottlieb's views on dietary supplements and his strong support for appropriate use of truthful and nonmisleading scientific information are consistent with industry views and an indication that FDA will be able to work effectively with the industry under Dr. Gottlieb's leadership."

Background

Dr. Scott Gottlieb was confirmed as FDA commissioner by the U.S. Senate on May 9. During a recent Senate committee hearing, Dr. Gottlieb testified that he uses dietary supplements every day, supports consumer access to these products and believes "they serve an important role in health promotion for millions of Americans." He also said that he believes "the regulatory framework established under DSHEA is the right one" and would be committed to "enforcing DSHEA, as intended by Congress."

Print

Number of views (3183)/Comments (0)


2017 Annual Fund Sponsors

           

AHPA appreciates the support of its sponsors, but does not endorse, recommend, or provide a warranty for any sponsor company, its products or services. AHPA has no responsibility for any transaction entered into with any of these companies.